Programmed cell death 1 (PD-1) inhibitor, a recently introduced therapy that breaks the PD-1/PD ligand 1 (PD-L1) linkage, is widely used in numerous cancer treatments (10, 11). The gene discussed is PDCD1; the disease is cancer.